$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
吡托布鲁替尼(Pirtobrutinib)是治疗什么疾病的
2025-10-19 11:44:20
Check Details
吡托布鲁替尼(Pirtobrutinib)的功效与作用详情
2025-10-19 11:44:20
Check Details
比卡鲁胺治疗前列腺癌会不会出现药物依赖性吗?
2025-10-19 11:44:20
Check Details
奥拉帕尼已获批用于前列腺癌患者的治疗
2025-10-19 11:44:20
Check Details
卡博替尼适应症之前列腺癌
2025-10-19 11:44:20
Check Details
奥拉帕尼获批治疗前列腺癌
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗晚期前列腺癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗转移性前列腺癌
2025-10-19 11:44:20
Check Details
奥拉帕尼延长前列腺癌患者生存期
2025-10-19 11:44:20
Check Details
奥拉帕尼前列腺癌靶向药物
2025-10-19 11:44:20
Check Details
卡博替尼治疗前列腺癌患者
2025-10-19 11:44:20
Check Details
奥拉帕尼治疗前列腺癌
2025-10-19 11:44:20
Check Details
1
2
...
7346
7347
7348
7349
7350
7351
7352
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
2
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
3
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
4
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
5
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
6
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
7
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
8
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
9
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
10
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management
11
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
12
Complete Guide to Dosage and Dose Adjustment of Entrectinib